In 2022, these ten major changes will deeply affect the Chinese medical community!

The medical insurance reform continues to upgrade 2.0, the Internet medical care continues to burn money, and social medical services are still a necessary supplement to the main framework... In 2022, these areas may have big moves.

Image | Figureworm creative

Global epidemic prevention and control and China's choice

Iterative of new coronavirus strains, continuous vaccination of vaccines, the glue state of global new crown epidemic prevention and control continues, the virus continues to adapt to human beings, "the new doctors on the sick day are also advancing day by day, and the new diseases on the medical days are also advancing day by day", the infectivity of the new crown is not reduced or even higher, but the case fatality rate is declining, and the countries around the world continue to swing in controlling the epidemic and developing the economy and the open society, but they are also helpless, running in accordance with the "new crown flu" + "lying flat open" model, which is the common painful choice of all countries in the world.

On the basis of national vaccination, China continues to adhere to the domestic and international dual-cycle strategy, prudently opens the country's doors and normalizes the dynamic clearance of the epidemic situation, and the immunization breakthrough of new strains continues to issue examination papers to provinces and cities.

The contribution of international and domestic pharmaceutical companies in the screening of vaccines and virus-specific drugs such as mRNA/inactivation needs to be further upgraded, and the normalization of the prevention and control of the new crown epidemic will continue until more perfect and efficient vaccines and specific drugs are truly found. Hopefully, the second half of 2022 will see a major breakthrough in medical science.

The health insurance reform continues to upgrade 2.0

The national medical insurance has continued to upgrade 2.0 in the construction of the system and the promotion of measures. Continue to promote the interconnection of medical insurance in various provinces across the country, the pricing scale procurement of pharmaceutical consumables, the reform of DIP/DRG payment methods, and the upgrading of medical insurance convenience IT. The balance of the medical insurance fund in the economic imbalance of various provinces and cities is also unbalanced, and how to improve the balance and fairness at the national level needs to be further explored by policy.

Big Health Pharmaceutical stocks continued to grow steadily

When the per capita GDP steps on the ladder of 10,000 US dollars, the people's attention to the good life and personal health will further escalate, the growth elasticity of health care costs will continue to be higher than the growth rate of GDP, and the proportion of the big health industry to GDP will gradually rise from 6% to 8% to 10% in the next 10 to 15 years. Under the background of continued improvement in fundamentals, big health and biomedical technology stocks will continue to be a stable and sustained growth sector after experiencing the hot spot in 2020 and the deeper correction in the second half of 2021.

Internet medical burning money continues

Internet medical companies continue to experience a "very valuable, but difficult to charge" difficult and difficult state of burning money, if medical insurance from clinical payments to upgrade health management payments, to the Internet companies to carry out chronic disease drugs express delivery and other payment quotas open, the real scale of income spring may come.

Internet pharmacies continue to flourish, but if a new "medicine for medicine" deformed ecology of the Internet is formed, the industry needs to further rectify the norms.

Pharmaceutical high-value consumables range from price wars to value wars

The pharmaceutical and high-value consumables industry continues to undergo large-scale reshuffle under the background of the pricing and collection of national medical insurance "4+7" group purchases, and continues to experience extreme stress tests and difficult survival. With the process of upgrading the national medical insurance pricing strategy from the "price war" to the "value war", pharmaceutical and high-value consumables companies have gradually begun to pay attention to research and development and global new product mergers and acquisitions, and in the next few years, companies with excellent troika of "R&D investment" + "three-dimensional sales" + "global mergers and acquisitions" will be encouraged.

The 5-year survival rate of tumors has entered a golden decade of steady improvement

There is a large gap between the 5-year survival rate of tumors in China and the United States, which is still about 40% to 43%, and the United States is above the level of 70%, and the difference is mainly in the promotion of early screening, standardized treatment and application of new technologies. With the gradual promotion of early tumor screening, the standardization of tumor diagnosis and treatment and the attention to the comprehensive treatment of side effects, the wide application of molecular testing and pathological precision detection technology, the continuous introduction and continuous upgrading of targeted drugs and immune drugs, and the improvement of medical insurance coverage of tumor diagnosis and treatment technology, from 2020 to 2030, China will enter the golden decade of stable improvement of tumor 5-year survival rate.

The equalization of basic health services is more effective

On the road of well-off and common prosperity for all, governments at all levels have promoted the high-quality development of public hospitals through various ways, while increasing investment in the construction of multi-hospital areas, new hospital trusteeship, telemedicine, the construction of the medical federation health community service network, and the construction of national regional medical centers, so that the fairness, accessibility and sense of access of medical and people's livelihood in various places have been further enhanced.

Rural health care still requires the state system and the financial resources of the state

The treatment of rural doctors, the management system and the improvement of professional capabilities need to be further concerned, so that the fairness and accessibility of rural medical care can be further improved.

This problem is understood from the perspective of common prosperity, relying on the implementation of various layers of various localities is obviously uneven, and the need to establish a national medical system for general practitioners in rural Areas of China should be mainly solved by the central government, and the overall improvement of the national average of rural medical and people's livelihood.

Aging and the aging medical system are valued

There are 264 million elderly people over the age of 60 in China, accounting for 18.7% of the total population of the country; 190 million people over the age of 65, accounting for 13.5% of the total population of the country. Providing cost-effective services that are appropriate to the financial resources of the country and each household requires strategic thinking and institutional construction. The so-called old medicine includes a coherent service system and guarantee system such as medicine (treatment), health (restoration), nursing (treatment), and nursing (old) and so on. At present, geriatric medicine, geriatric rehabilitation, elderly nursing, medical and nursing care integrated pension is gradually emerging, home type, day care type, hospitalization type and other pension methods are gradually being built, long-term care and care insurance will be gradually piloted in various places and implemented according to efforts.

Social medical care is still a necessary supplement to the main framework

The number of social medical institutions continues to develop rapidly, but the absolute service volume is still only a necessary and useful supplement to the main medical service framework, and the system risk of the overall institutional adjustment of the industry does not exist. The direction of development is: specialized specialty medical treatment, high-quality outpatient services, new health consumption medical treatment, tertiary hospital upstream and downstream and medical insurance payment cooperation network.

Sources | the health community

Contributing author | Zhang Binyun

Note: This article is authorized by Mr. Zhang Binyun to be first published in the health industry, if you need to reprint, please clearly indicate the source and author, otherwise it will be regarded as infringement.

About the author: Zhang Binyun, founder of Ciyi Medical Foundation and deputy director of the Institute of Hospital Management of Fudan University. He once served as the deputy director of the Hospital Management Office of Fudan University, the general manager of Fudan Medical Industry Investment Company, the chairman of Fudan Hospital Management Company, the vice chairman of the Health Management Branch of Shanghai Medical Association, and the executive vice president of China Health Resources Magazine. He is one of the drafters of the National Medical Reform and Shanghai Medical Reform Fudan Program, one of the founders of the Fudan Hospital President Advanced Training Program, and one of the main implementing members of the logistics socialization reform of fudan system affiliated hospitals. Familiar with the health reform of various countries, the reform of China's public hospitals and the guidance of the formulation of medical reform plans in many places.